EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

South Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes ...

The researchers also examined potential health risks linked to cannabis use. Long-term data from adolescents suggested that ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

A tenuous connection between hormone therapy and increased dementia risk was noted, but more research is warranted. In A ...

Olema Pharmaceuticals (OLMA) earns a "Strong Buy" rating, driven by advancing palazestrant for 1st-line ER+/HER2- metastatic ...

This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...

Study Links Mediterranean Diet to Lower Multiple Sclerosis Risk Levels Eating your way to brain health might be simpler than ...

A new study suggests that the average person may be far more aware of their own lack of political knowledge than previously ...